Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Current Assets (2020 - 2025)

Historic Current Assets for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to $14.4 million.

  • Biofrontera's Current Assets fell 1487.21% to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.4 million, marking a year-over-year decrease of 1487.21%. This contributed to the annual value of $20.7 million for FY2024, which is 1029.25% down from last year.
  • Per Biofrontera's latest filing, its Current Assets stood at $14.4 million for Q3 2025, which was down 1487.21% from $18.8 million recorded in Q2 2025.
  • Biofrontera's 5-year Current Assets high stood at $48.5 million for Q3 2022, and its period low was $10.1 million during Q3 2021.
  • Moreover, its 5-year median value for Current Assets was $21.9 million (2023), whereas its average is $28.2 million.
  • Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 37837.62% in 2022, then tumbled by 4651.14% in 2023.
  • Quarter analysis of 5 years shows Biofrontera's Current Assets stood at $46.4 million in 2021, then dropped by 7.07% to $43.1 million in 2022, then tumbled by 46.51% to $23.1 million in 2023, then fell by 10.29% to $20.7 million in 2024, then tumbled by 30.37% to $14.4 million in 2025.
  • Its last three reported values are $14.4 million in Q3 2025, $18.8 million for Q2 2025, and $15.3 million during Q1 2025.